This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Unless otherwise indicated, all forward looking statements are based on estimates, projections, and assumptions of MaxLinear as of the date of this presentation. These forward-looking statements include, among others, statements concerning: our expected financial performance for the fourth quarter of 2025; our p ...

Financial Performance (Q1'25) - Revenue was $95.9 million[5, 7, 8], a slight increase compared to $92.2 million in Q4'24 but similar to $95.3 million in Q1'24[7, 8] - GAAP gross margin was 56.1%[5, 7], while non-GAAP gross margin was 59.1%[5, 8] - GAAP operating margin was (48)%[5], and non-GAAP operating margin was (2)%[5] - GAAP diluted loss per share was $(0.58)[5, 7], and non-GAAP diluted loss per share was $(0.05)[5, 8] - Cash used in operations was $11.4 million[5] Balance Sheet (Q1'25) - Cash and cash equivalents and restricted cash totaled $102.8 million[9], a decrease from $119.6 million in Q4'24 and $192.9 million in Q1'24[9] - Total assets were $855.3 million[9], down from $864.6 million in Q4'24 and $1.0306 billion in Q1'24[9] - Total liabilities amounted to $362.1 million[9], compared to $348.4 million in Q4'24 and $392.6 million in Q1'24[9] Q2'25 Guidance - Revenue is expected to be between $95 million and $115 million[10] - GAAP gross margin is projected to be 54.5% to 57.5%[10], while non-GAAP gross margin is expected to be 57.5% to 60.5%[10] - GAAP operating expenses are estimated to be $92 million to $98 million[10], and non-GAAP operating expenses are projected to be $55 million to $61 million[10]